Quest Diagnostics is UNDERVALUED at 136.63 per share with modest projections ahead. Quest Diagnostics appears to be very steady, given 1 month investment horizon.
Quest Diagnostics maintains Sharpe Ratio (i.e. Efficiency) of 0.15, which implies the firm had 0.15% of return per unit of risk over the last month. Our standpoint towards forecasting the volatility of a stock is to use all available market data together with stock specific
technical indicators that cannot be
diversified away. We have found twenty-eight
technical indicators for Quest Diagnostics, which you can use to evaluate future volatility of the company. Please employ Quest Diagnostics
coefficient of variation of 478.91,
semi deviation of 1.47, and
risk adjusted performance of 0.3581 to confirm if our risk estimates are consistent with your expectations.
Typically, a company's
financial statements are the reports that show the
financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Quest Diagnostics income statement, its balance sheet, and the statement of cash flows. Potential Quest Diagnostics investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Quest Diagnostics investors may use each financial statement separately, they are all related. The changes in Quest Diagnostics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Quest Diagnostics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our
technical analysis and
fundamental analysis pages.
The goal of Quest Diagnostics
fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Quest Diagnostics performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Quest Diagnostics shares is the value that is considered the true value of the share. If
the intrinsic value of Quest is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Quest Diagnostics. Please read more on our
fundamental analysis page.
How effective is Quest Diagnostics in utilizing its assets?
Quest Diagnostics Incorporated reports assets on its Balance Sheet. It represents the amount of Quest resources that either has an existing economic value or will provide some form of benefits in the future. By effectively utilizing its assets, Quest Diagnostics aims to generate revenue, control costs, drive operational efficiency, and enhance profitability. Optimizing asset utilization helps maximize shareholder value and maintain a competitive position in the Health Care Providers & Services space. To get a better handle on how balance sheet or income statements item affect Quest volatility, please check the breakdown of all its
fundamentals.
Are Quest Diagnostics Earnings Expected to grow?
The
future earnings power of Quest Diagnostics involves the interaction of many company-specific, industry, and economic forces. Earnings estimates embody investors' opinions of Quest Diagnostics factors such as sales growth, product demand, competitive industry environment, profit margins, and cost controls. Quest Diagnostics
stock prices adjust as these expectations change or are proven wrong. The main thing to remember is that equities with high expected earnings growth tend to underperform the market because it is usually difficult to meet the market's high expectations. Companies with low earnings expectations tend to do better than expected. Please use our latest analysis of Quest
expected earnings.
And What about dividends?
A dividend is the distribution of a portion of Quest Diagnostics earnings, decided and managed by the company's board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. Quest Diagnostics dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment. Quest one year expected dividend income is about USD1.86 per share.
At this time, Quest Diagnostics'
Dividends Paid is fairly stable compared to the past year.
Dividend Yield is likely to rise to 0.02 in 2024, whereas
Dividend Paid And Capex Coverage Ratio is likely to drop
(14.21) in 2024.
Investing in dividend-paying stocks, such as Quest Diagnostics Incorporated is one of the few strategies that are good for long-term investment. Ex-dividend dates are significant because investors in Quest Diagnostics must own a stock before its ex-dividend date to receive its next dividend.
This type of analysis is very useful when you want to generate a past dividend schedule and payout information for Quest Diagnostics. Then that information in the form of graph and calendar can be used to fully explain how Du Pont dividends can provide a real clue to its valuation.
Quest Diagnostics Gross Profit
Quest Diagnostics Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Quest Diagnostics previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Quest Diagnostics Gross Profit growth over the last 10 years. Please check Quest Diagnostics'
gross profit and other
fundamental indicators for more details.
What is driving Quest Diagnostics Investor Appetite?
There are few distinct groups of Quest Diagnostics stakehholders that the SEC considers insiders. Investors usually gain information through their work as corporate directors, officers, or employees. If these individuals share the information with a friend, family, or business partner and the person who receives the information exchanges stock in the company, he or shie is also an insider. Let's take a look at how the ownership of Quest is distributed among investors.
Ownership Allocation
Quest Diagnostics owns a total of one hundred thirty-three million seven hundred twenty-nine thousand nine hundred ninety-nine
outstanding shares. The majority of Quest Diagnostics Incorporated
outstanding shares are owned by
third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Quest Diagnostics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Quest Diagnostics. Please pay attention to any change in the institutional holdings of Quest Diagnostics as this could imply that something significant has changed or about to change at the company. Please note that no matter how much assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
| Retail Investors5.32% | | Institutions94.17% |
| Retail Investors | 5.32 |
| Insiders | 0.51 |
| Institutions | 94.17 |
Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Quest Diagnostics has an asset utilization ratio of 76.89 percent. This suggests that the company is making $0.77 for each dollar of assets. An increasing asset utilization means that Quest Diagnostics Incorporated is more efficient with each dollar of assets it utilizes for everyday operations.
| Assets Non Current10.3 B | Goodwill8 B | |
| Current Assets | 2.23 Billion | 10.75 |
| Assets Non Current | 10.26 Billion | 49.51 |
| Goodwill | 8.05 Billion | 38.82 |
| Tax Assets | 190.93 Million | 0.92 |
Will Quest pull back in August 2020?
Quest Diagnostics current downside deviation rises over 1.79. As of the 23rd of July, Quest Diagnostics holds the
semi deviation of 1.47,
risk adjusted performance of 0.3581, and
coefficient of variation of 478.91. Quest Diagnostics
technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen
technical drivers for Quest Diagnostics, which can be compared to its competitors. Please check
Quest Diagnostics standard deviation, as well as the
relationship between the
maximum drawdown and
expected short fall to decide if Quest Diagnostics is priced some-what accurately, providing market reflects its current price of 129.76 per share. Given that Quest Diagnostics has
jensen alpha of 0.4547, we recommend you to check out Quest Diagnostics's recent market performance to make sure the company can sustain itself at a future point.
While some other firms under the diagnostics & research industry are still a bit expensive, Quest Diagnostics may offer a potential longer-term growth to investors. With an optimistic outlook on your 30 days horizon, it may be a good time to take in new shares of Quest or increase your existing holdings in the Stock as it seems the potential growth has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Quest Diagnostics.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Quest Diagnostics Incorporated. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com